Comorbidity Projects funded by MHDAO
- An open label pilot study of Rimonabant, a cannabinoid receptor antagonist, for over 18 cannabis users with a history of psychosis participating in a structured treatment program.
- Treating comorbid post traumatic stress disorder (PTSD) and amphetamine dependence.
- Early intervention for substance misuse in young people at high risk for psychosis and in first episode psychosis.
- Co- occurring mental illness and substance use disorder amongst Australian Prisoners
- CBT intervention for regular amphetamine use and depression: a stepped care approach.
- The impact of cannabis use on neuropsychological function in schizophrenia.
- Novel treatments for young people with harmful alcohol use: A trial of structured stepped-care intervention for psychiatric comorbidity.